1,990
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Renin–angiotensin system inhibitor and statins combination therapeutics – what have we learnt?

, MD PhD, , MD PhD, , MD PhD, , MD PhD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eduardo Filipe Oliveira, Diogo Santos-Martins, António Meireles Ribeiro, Natércia Fernandes Brás, Nuno Sousa Cerqueira, Sérgio Filipe Sousa, Maria João Ramos & Pedro Alexandrino Fernandes. (2016) HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015). Expert Opinion on Therapeutic Patents 26:11, pages 1257-1272.
Read now

Articles from other publishers (11)

Andrea Lopez-Lopez, Rita Valenzuela, Ana Isabel Rodriguez-Perez, María J. Guerra, Jose Luis Labandeira-Garcia & Ana Muñoz. (2023) Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia. Antioxidants 12:7, pages 1454.
Crossref
Sabrina Mota, Johanna Bensalel, Do Hee Park, Sandra Gonzalez, Ana Rodriguez & Julio Gallego-Delgado. (2022) Treatment Reducing Endothelial Activation Protects against Experimental Cerebral Malaria. Pathogens 11:6, pages 643.
Crossref
Guido Grassi, Rita Del Pinto, Claudia Agabiti Rosei, Davide Agnoletti, Claudio Borghi, Arrigo F. G. Cicero, Carolina De Ciuceis, Giovambattista Desideri, Davide Grassi, Maria Lorenza Muiesan, Anna Paini, Massimo Salvetti, Giuliano Tocci, Franco Veglio, Massimo Volpe & Claudio Ferri. (2022) Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension. High Blood Pressure & Cardiovascular Prevention 29:2, pages 105-113.
Crossref
Ki Young Huh, Sang Won Lee, Si Beum Lee, Kyung Tae Kim, In‐Jin Jang & SeungHwan Lee. (2021) Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan. Clinical Pharmacology in Drug Development 10:11, pages 1290-1296.
Crossref
Jeong-a Kim. (2021) Insulin Resistance and Cardiometabolic Syndrome. CardioMetabolic Syndrome Journal 1:1, pages 24.
Crossref
Odunayo Michael Agunloye & Ganiyu Oboh. (2018) Hypercholesterolemia, angiotensin converting enzyme and ecto-enzymes of purinergic system: Ameliorative properties of caffeic and chlorogenic acid in hypercholesterolemic rats. Journal of Food Biochemistry 42:5, pages e12604.
Crossref
Kwang Kon KohIchiro SakumaKazunori ShimadaToshio HayashiMichael J. Quon. (2017) Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events. Korean Circulation Journal 47:4, pages 432.
Crossref
Kwang Kon Koh, Seung Hwan Han, Ichiro Sakuma & Dong Zhao. (2016) Calming down chaos regarding redefining blood pressure targets-the importance of statin-based therapy. International Journal of Cardiology 221, pages 572-574.
Crossref
Pyung Chun Oh, Ichiro Sakuma, Toshio Hayashi & Kwang Kon Koh. (2016) Angiotensin converting enzyme inhibitors remain the first treatment of choice. The Korean Journal of Internal Medicine 31:2, pages 237-241.
Crossref
Elena Cini, Luca Banfi, Giuseppe Barreca, Luca Carcone, Luciana Malpezzi, Fabrizio Manetti, Giovanni Marras, Marcello Rasparini, Renata Riva, Stephen Roseblade, Adele Russo, Maurizio Taddei, Romina Vitale & Antonio Zanotti-Gerosa. (2016) Convergent Synthesis of the Renin Inhibitor Aliskiren Based on C5–C6 Disconnection and CO 2 H–NH 2 Equivalence . Organic Process Research & Development 20:2, pages 270-283.
Crossref
Kwang Kon Koh, Pyung Chun Oh & Ichiro Sakuma. (2016) Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf. International Journal of Cardiology 202, pages 154-155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.